Farmacia Hospitalaria y Farmacogenómica

Amor-Garcia, MA; Ibanez-Garcia, S; Diaz-Redondo, A; Alonso, AH; Saez, MS.

Multidisciplinary strategy to reduce errors with the use of medical gases

FARMACIA HOSPITALARIA. 2018; 42(3): 103-107 Nº de citas: 1 [doi:10.7399/fh.10920]

Marzal-Alfaro, MB; Barbero, MLM; Dominguez, JMG; Romero-Delgado, F; Gines, MLM; Herranz, A; Sanjurjo-Saez, M.

Impact of fampridine on quality of life: clinical benefit in real-world practice

EUROPEAN JOURNAL OF HOSPITAL PHARMACY. 2018; 25(3): 138-143 Nº de citas: 6 [doi:10.1136/ejhpharm-2016-001129]

Bouza, E; Valerio, M; Soriano, A; Morata, L; Carus, EG; Rodriguez-Gonzalez, C; Hidalgo-Tenorio, MC; Plata, A; Munoz, P; Vena, A.

Dalbavancin in the treatment of different gram-positive infections: a real-life experience

INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS. 2018; 51(4): 571-577 Nº de citas: 140 [doi:10.1016/j.ijantimicag.2017.11.008]

Escudero-Vilaplana, V; Osorio-Prendes, S; Collado-Borrell, R; Gonzalez-Arias, E; Sanjurjo-Saez, M.

Eosinophilia secondary to lenalidomide therapy

JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS. 2018; 43(2): 273-275 Nº de citas: 3 [doi:10.1111/jcpt.12611]

Crespo-Martinez, C; Sirvent-Ochando, M; Vazquez-Polo, A; Caba-Porras, I; Romero-Jimenez, RM; Telada-Gonzalez, P.

Survey on the use of zinc sulfate in parenteral nutrition in spanish hospitals

FARMACIA HOSPITALARIA. 2018; 42(2): 68-72 Nº de citas: 2 [doi:10.7399/fh.10855]

Fuentes-Irigoyen, R; Cabrera, AMMD; Riestra, AC; Vila, MN; Davila-Pousa, C; Herreros, JMA; Lopez-Cabezas, C; Canete, C; Pernia-Lopez, MS; Garcia-Palomo, M; Villalobos, PA; Ibares-Frias, L; Segura, JLU; Martinez, JRY.

Consensus SEO-SEFH of recommendations for use and compounding of ophthalmic preparations

FARMACIA HOSPITALARIA. 2018; 42(2): 82-88 Nº de citas: 4 [doi:10.7399/fh.10943]

López-Herce Cid J; Rodríguez Núñez A; Carrillo Álvarez Á; Zeballos Sarrato G; Martínez Fernández-Llamazares C; Calvo Macías C; Grupo Español de Reanimación Cardiopulmonar Pediátrica y Neonatal.

Recomendaciones de expertos sobre el material del carro y mochila de reanimacion cardiopulmonar pediatrica y neonatal.

ANALES DE PEDIATRIA. 2018; 88(3): [doi:10.1016/j.anpedi.2017.05.010]

Mañes-Sevilla M; Marzal-Alfaro MB; Romero Jiménez R; Herranz-Alonso A; Sanchez Fresneda MN; Benedi Gonzalez J; Sanjurjo-Sáez M.

Analisis modal de fallos y efectos para mejorar la calidad en los ensayos clinicos.

Journal Of Healthcare Quality Research. 2018; 33(1): 33-47 Nº de citas: 1 [doi:10.1016/j.cali.2017.12.001]

Galve-Calvo, E; Gonzalez-Haba, E; Gostkorzewicz, J; Martinez, I; Perez-Mitru, A.

Cost-effectiveness analysis of ribociclib versus palbociclib in the first-line treatment of HR+/HER2- advanced or metastatic breast cancer in Spain

ClinicoEconomics and Outcomes Research. 2018; 10: 773-790 Nº de citas: 20 [doi:10.2147/CEOR.S178934]

Garcia-Gonzalez, X; Lopez-Tarruella, S; Garcia, MI; Gonzalez-Haba, E; Blanco, C; Salvador-Martin, S; Jerez, Y; Thomas, F; Jarama, M; Saez, MS; Martin, M; Lopez-Fernandez, LA.

Severe toxicity to capecitabine due to a new variant at a donor splicing site in the dihydropyrimidine dehydrogenase (DPYD) gene

Cancer Management and Research. 2018; 10: 4517-4522 Nº de citas: 4 [doi:10.2147/CMAR.S174470]

Gonzalez, J; Quiroga, M; Escudero-Vilaplana, V; Collado-Borrell, R; Herranz-Alonso, A; Saez, MS.

Posology adjustments of oral antineoplastic agents for special populations: patients with renal impairment, hepatic impairment and hematologic toxicities

EXPERT OPINION ON DRUG SAFETY. 2018; 17(6): 553-572 Nº de citas: 9 [doi:10.1080/14740338.2018.1477937]

De Andres, C; Garcia, MI; Goicoechea, H; Martinez-Gines, ML; Garcia-Dominguez, JM; Martin, ML; Romero-Delgado, F; Benguria, A; Sanjurjo, M; Lopez-Fernandez, LA.

Genes differentially expressed by methylprednisolone in vivo in CD4 T lymphocytes from multiple sclerosis patients: potential biomarkers

PHARMACOGENOMICS JOURNAL. 2018; 18(1): 98-105 Nº de citas: 14 [doi:10.1038/tpj.2016.71]

Chamorro-de-Vega, E; Gimenez-Manzorro, A; Rodriguez-Gonzalez, CG; Escudero-Vilaplana, V; De Lorenzo-Pinto, A; Iglesias-Peinado, I; Herranz-Alonso, A; Saezon, MS.

Twelve weeks of ombitasvir/paritaprevir/r and dasabuvir without ribavirin is effective and safe in the treatment of patients with HCV genotype 1b infection and compensated cirrhosis: results from a real-world cohort study

EXPERT OPINION ON DRUG SAFETY. 2018; 17(3): 235-241 Nº de citas: 3 [doi:10.1080/14740338.2018.1424829]

Revuelta-Herrero, JL; Chamorro-De-Vega, E; Rodriguez-Gonzalez, CG; Alonso, R; Herranz-Alonso, A; Sanjurjo-Saez, M.

Effectiveness, Safety, and Costs of a Treatment Switch to Dolutegravir Plus Rilpivirine Dual Therapy in Treatment-Experienced HIV Patients

ANNALS OF PHARMACOTHERAPY. 2018; 52(1): 11-18 Nº de citas: 48 [doi:10.1177/1060028017728294]

de Lorenzo-Pinto, A; Herranz-Alonso, A; Cuellar-Basterrechea, B; Bellon-Cano, JM; Sanjurjo-Saez, M; Bueno, H.

Clinical and Economic Impact of a Multisciplinary Intervention to Reduce Bleeding Risk in Patients With Acute Coronary Syndrome

REVISTA ESPANOLA DE CARDIOLOGIA. 2017; 70(10): 825-831 Nº de citas: 5 [doi:10.1016/j.recesp.2016.12.020]

Galar, A; Valerio, M; Munoz, P; Alcala, L; Garcia-Gonzalez, X; Burillo, A; Sanjurjo, M; Grau, S; Bouza, E.

Systematic Therapeutic Drug Monitoring for Linezolid: Variability and Clinical Impact

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY. 2017; 61(10): Nº de citas: 21 [doi:10.1128/AAC.00687-17]

Pellicer, M; Garcia-Gonzalez, X; Garcia, MI; Blanco, C; Garcia-Alfonso, P; Robles, L; Gravalos, C; Rueda, D; Martinez, J; Pachon, V; Longo, F; Martinez, V; Iglesias, I; Salvador, S; Sanjurjo, M; Lopez-Fernandez, LA.

Use of exome sequencing to determine the full profile of genetic variants in the fluoropyrimidine pathway in colorectal cancer patients affected by severe toxicity

PHARMACOGENOMICS. 2017; 18(13): 1215-1223 Nº de citas: 11 [doi:10.2217/pgs-2017-0118]

Chamorro-de-Vega, E; Rodriguez-Gonzalez, CG; Gimenez-Manzorro, A; de Lorenzo-Pinto, A; Iglesias-Peinado, I; Herranz, A; Sanjurjo, M.

Improving pharmacotherapy outcomes in patients with hepatitis C virus; infection treated with direct-acting antivirals: The GRUviC project

INTERNATIONAL JOURNAL OF CLINICAL PRACTICE. 2017; 71(8): Nº de citas: 8 [doi:10.1111/ijcp.12988]